Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioblastoma × Ultrasonography × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Prostatic Neoplasms 7 Thyroid Nodule 3 Squamous Cell Carcinoma of Head and Neck 3 Sarcopenia 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 3 Neoplasms 3 Mouth Neoplasms 3 Liver Neoplasms 3 Liver Cirrhosis 3 Endometrial Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Thyroid Neoplasms 2 Ovarian Neoplasms 2 Ovarian Cysts 2 Lung Neoplasms 2 Hypersensitivity 2 Head and Neck Neoplasms 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Thrombosis 1 Thoracic Neoplasms 1 Testicular Neoplasms 1 Solid Tumor 1

Interventions

Temozolomide 244 Radiotherapy 112 Bevacizumab 94 Magnetic Resonance Spectroscopy 50 Radiation 43 pembrolizumab 29 Irinotecan 27 Lomustine 20 Surgical Procedures, Operative 18 Radiosurgery 18 Nivolumab 17 Carmustine 16 Specimen Handling 15 Erlotinib Hydrochloride 15 Aminolevulinic Acid 15 Radiotherapy, Intensity-Modulated 13 Drug Therapy 12 Chemotherapy, Adjuvant 12 Carboplatin 12 Blood Specimen Collection 12 O(6)-benzylguanine 11 Cyclophosphamide 11 sargramostim 10 Thalidomide 10 Filgrastim 9 Etoposide 9 poly ICLC 8 Sunitinib 8 Imatinib Mesylate 8 Everolimus 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05062772 2024-11-15

BraTioUS-DB

Hospital del Rio Hortega

Brain Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡